Foreign establishment registration
This article was originally published in The Gray Sheet
Proposed rule issued May 14 would require all foreign establishments whose products are imported or offered for import into the U.S. to register with FDA, as required by Sec. 417 of the FDA Modernization Act. Prior to FDAMA, foreign manufacturers were required only to list their U.S. marketed products with the agency
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.